Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Jazz Pharmaceuticals Inc (JAZZ)  
$109.27 0.37 (0.34%) as of 4:30 Thu 4/18


Download
   
Exchange: Nasdaq National Market
Security Type: N/A
Shares Out: 61,150,000
Market Cap: 6.68(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $113.49 - $145.93
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Jazz Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing medicines for patients with serious diseases with limited or no options. Co.'s primary marketed products are: Xyrem® (sodium oxybate) oral solution, for the treatment of both cataplexy and excessive daytime sleepiness (EDS) in narcolepsy patients seven years of age and older; Xywav™ (calcium, magnesium, potassium, and sodium oxybates) oral solution, for the treatment of cataplexy or EDS in narcolepsy patients seven years of age and older; and Sunosi® (solriamfetol), to improve wakefulness in adult patients with EDS associated with narcolepsy or obstructive sleep apnea.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 12,000 12,000 12,000 12,000
Total Buy Value $1,435,800 $1,435,800 $1,435,800 $1,435,800
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 3,704 4,538 27,327 209,575
Total Sell Value $438,449 $537,921 $3,641,323 $30,724,059
Total People Sold 1 3 13 19
Total Sell Transactions 2 4 21 80
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 1249
  Page 1 of 50  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gala Renee D President & COO   •       –      –    2024-04-05 4 D $115.21 $200,005 D/D (1,736) 55,357     -
   Carr Patricia SVP, Chief Accounting Officer   •       –      –    2024-03-07 4 S $116.98 $206,821 D/D (1,768) 6,596     -
   Carr Patricia SVP, Chief Accounting Officer   •       –      –    2024-03-06 4 S $117.51 $231,628 D/D (1,936) 8,364     -
   Iannone Robert EVP, Global Head of R&D   •       –      –    2024-03-05 4 D $117.53 $504,674 D/D (4,294) 62,226     -
   Patil Neena M EVP & Chief Legal Officer   •       –      –    2024-03-05 4 D $117.53 $403,363 D/D (3,432) 41,629     -
   Pearce Samantha SVP, Head of Europe & Internat   •       –      –    2024-03-05 4 D $117.53 $290,769 D/D (2,474) 16,922     -
   Cozadd Bruce C Chairman & CEO   •       •      –    2024-03-05 4 D $117.53 $2,636,903 D/D (22,436) 429,809     -
   Gala Renee D President & COO   •       –      –    2024-03-05 4 D $117.53 $425,694 D/D (3,622) 57,093     -
   Gala Renee D President & COO   •       –      –    2024-03-01 4 A $0.00 $0 D/D 19,916 60,715     -
   Pearce Samantha SVP, Head of Europe & Internat   •       –      –    2024-03-01 4 A $0.00 $0 D/D 5,065 19,396     -
   Iannone Robert EVP, Global Head of R&D   •       –      –    2024-03-01 4 A $0.00 $0 D/D 16,928 66,520     -
   Cozadd Bruce C Chairman & CEO   •       •      –    2024-03-01 4 A $0.00 $0 D/D 50,187 452,245     -
   Kennedy Patrick Director   –       •      –    2024-03-01 4 A $0.00 $0 D/D 1,423 1,423     -
   Johnson Philip L EVP & Chief Financial Officer   •       –      –    2024-03-01 4 B $119.65 $1,435,800 D/D 12,000 27,932 2.74     -
   Johnson Philip L EVP & Chief Financial Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 15,932 15,932     -
   Patil Neena M EVP & Chief Legal Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 12,348 45,061     -
   Carr Patricia SVP, Chief Accounting Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 2,987 10,300     -
   Henderson Mary Elizabeth SVP, Technical Operations   •       –      –    2024-03-01 4 A $0.00 $0 D/D 5,178 15,941     -
   Iannone Robert EVP, Global Head of R&D   •       –      –    2024-01-17 4 D $119.13 $206,095 D/D (1,730) 49,592     -
   Iannone Robert EVP, Global Head of R&D   •       –      –    2024-01-17 4 A $0.00 $0 D/D 5,970 51,322     -
   Gala Renee D President & COO   •       –      –    2024-01-17 4 D $119.13 $381,693 D/D (3,204) 40,799     -
   Gala Renee D President & COO   •       –      –    2024-01-17 4 A $0.00 $0 D/D 7,079 44,003     -
   Pearce Samantha SVP, Head of Europe & Internat   •       –      –    2024-01-17 4 D $119.13 $123,657 D/D (1,038) 14,331     -
   Pearce Samantha SVP, Head of Europe & Internat   •       –      –    2024-01-17 4 A $0.00 $0 D/D 2,210 15,369     -
   Carr Patricia SVP, Chief Accounting Officer   •       –      –    2024-01-17 4 A $0.00 $0 D/D 1,327 7,363     -
  1249 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 50
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us